Roche Diagnostics International Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Roche Diagnostics International Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7087
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Roche Diagnostics International Ltd (Roche Diagnostics), a subsidiary of F. Hoffmann-La Roche Ltd, is a provider of diagnostic system solutions to clinics, laboratories and doctors’ offices. The company develops, produces and services instruments and software systems used in in vitro diagnostics and bioanalytical research. It also offers diagnostic analysis systems and workflow solutions; and molecular diagnostic reagents and test systems. Its major products include point-of-care testing devices and blood glucose meters, among others. The company offers its products and services to hospitals, commercial diagnostic laboratories, healthcare professionals, researchers and pharmacists. It has operations in the Americas, Africa, the Middle East and Europe, among others. Roche Diagnostics manages all the central functions of the Diagnostics business of F. Hoffmann-La Roche Ltd and is headquartered in Rotkreuz, Switzerland.

Roche Diagnostics International Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Roche Diagnostics International Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Roche Diagnostics International Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Roche Diagnostics International Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Roche Diagnostics International Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Roche Diagnostics International Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Roche Diagnostics International Ltd, Medical Equipment, Deal Details 10
Asset Purchase 10
Roche Diagnostics to Acquire Tissue Dissection Technology from AvanSci Bio 10
Partnerships 11
Inotrem Enters into Research Agreement with Roche Diagnostics 11
Cellnovo Enters into Agreement with Roche Diagnostics 12
Molecular Devices Enters into Co-Development Agreement with Roche Diagnostics 13
Advanced Biological Labs Extends Co-Promotion Agreement with Roche Diagnostics 14
AUT University Forms Joint Venture with Roche Diagnostics 15
Genia Technologies Enters Into Agreement With Columbia University And Harvard Medical To Develop NanoTag DNA Sequencing Technology 16
Advanced Biological Labs And Roche Diagnostics Enter Into Agreement To Promote Sequencing, Genotyping And Drug Resistance Products 17
Genia Technologies Enters Into Co-Development Agreement With Columbia University And Harvard University 18
Sysmex Extends Distribution Agreement With Roche 19
Acquisition 20
Roche Diagnostics Acquires Genia for up to USD350 Million 20
Roche Diagnostics International Ltd – Key Competitors 21
Roche Diagnostics International Ltd – Key Employees 22
Roche Diagnostics International Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 23
Recent Developments 24
Corporate Communications 24
Aug 28, 2018: Changes to the Roche Executive Committee 24
Government and Public Interest 25
Mar 28, 2018: Life Science Leaders Gather at Medidata NEXT Basel and Frankfurt to Examine New Opportunities to Improve Clinical Development and Better Patient Lives 25
Product News 26
Dec 08, 2017: Oncolytic Adenovirus Expressing BiTE Effectively Recruits T Cells to Kill Diverse Cancer Cell Types 26
Other Significant Developments 27
Sep 17, 2018: IT technology development promotes medical inspection laboratories from automation to intelligence 27
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Roche Diagnostics International Ltd, Medical Equipment, Key Facts, 2017 2
Roche Diagnostics International Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Roche Diagnostics International Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Roche Diagnostics International Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Roche Diagnostics International Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Roche Diagnostics International Ltd, Deals By Market, 2012 to YTD 2018 8
Roche Diagnostics International Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Roche Diagnostics to Acquire Tissue Dissection Technology from AvanSci Bio 10
Inotrem Enters into Research Agreement with Roche Diagnostics 11
Cellnovo Enters into Agreement with Roche Diagnostics 12
Molecular Devices Enters into Co-Development Agreement with Roche Diagnostics 13
Advanced Biological Labs Extends Co-Promotion Agreement with Roche Diagnostics 14
AUT University Forms Joint Venture with Roche Diagnostics 15
Genia Technologies Enters Into Agreement With Columbia University And Harvard Medical To Develop NanoTag DNA Sequencing Technology 16
Advanced Biological Labs And Roche Diagnostics Enter Into Agreement To Promote Sequencing, Genotyping And Drug Resistance Products 17
Genia Technologies Enters Into Co-Development Agreement With Columbia University And Harvard University 18
Sysmex Extends Distribution Agreement With Roche 19
Roche Diagnostics Acquires Genia for up to USD350 Million 20
Roche Diagnostics International Ltd, Key Competitors 21
Roche Diagnostics International Ltd, Key Employees 22
Roche Diagnostics International Ltd, Subsidiaries 23
Roche Diagnostics International Ltd, Joint Venture 23

List of Figures
Roche Diagnostics International Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Roche Diagnostics International Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Roche Diagnostics International Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Roche Diagnostics International Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Roche Diagnostics International Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Roche Diagnostics International Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Roche Diagnostics International Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Roche Diagnostics International Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Roche Diagnostics International Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Leclanche SA (LECN):企業の財務・戦略的SWOT分析
    Leclanche SA (LECN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Empresas Publicas De Medellin ESP:企業の戦略的SWOT分析
    Empresas Publicas De Medellin ESP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • DURECT Corp (DRRX)-製薬・医療分野:企業M&A・提携分析
    Summary DURECT Corp (Durect) is a specialty pharmaceutical company. It carries out the development of pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. It also undertakes the development of biotechnology products. The company’s …
  • Blue Coat Systems, Inc.:企業のM&A・事業提携・投資動向
    Blue Coat Systems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Blue Coat Systems, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Davos Life Science Pte Ltd:企業の戦略・SWOT・財務情報
    Davos Life Science Pte Ltd - Strategy, SWOT and Corporate Finance Report Summary Davos Life Science Pte Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • University of Florida-製薬・医療分野:企業M&A・提携分析
    Summary University of Florida (UF) is an educational institute that offers undergraduate, graduate and distance learning programs. The institute offers educational programs in areas of agricultural, business administration, journalism and communications, law, dentistry, arts and sciences, medicine, …
  • Mindray Medical International Limited:企業の戦略・SWOT・財務分析
    Mindray Medical International Limited - Strategy, SWOT and Corporate Finance Report Summary Mindray Medical International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Selective Insurance Group, Inc. (SIGI):企業の財務・戦略的SWOT分析
    Selective Insurance Group, Inc. (SIGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Svenska Handelsbanken AB:企業のM&A・事業提携・投資動向
    Svenska Handelsbanken AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Svenska Handelsbanken AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Silver Lake Resources Limited:企業の戦略・SWOT・財務情報
    Silver Lake Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Silver Lake Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • The GPT Group (GPT):企業の財務・戦略的SWOT分析
    The GPT Group (GPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Centre for Drug Design and Discovery-製薬・医療分野:企業M&A・提携分析
    Summary Centre for Drug Design and Discovery (CD3) is a biomedical research institution that discovers new small molecule drugs. The institution provides services such as silico molecule design, modelling and screening, medicinal chemistry, intellectual property rights support, business development, …
  • Euler Hermes SA:戦略・SWOT・企業財務分析
    Euler Hermes SA - Strategy, SWOT and Corporate Finance Report Summary Euler Hermes SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • CROS NT srl-製薬・医療分野:企業M&A・提携分析
    Summary CROS NT srl (CROS NT) is a contract research organization (CRO), which specializes in clinical data management, analysis, reporting and technologies. Its services include programming, analysis, medical writing, CROS academy training, methodology and clinical data management. Its outsourcing …
  • Ebiquity plc (EBQ):企業の財務・戦略的SWOT分析
    Summary Ebiquity plc (Ebiquity) is a marketing and media consultancy service provider. The company offers services such as marketing performance optimization services, media value measurement and market intelligence. Its business areas comprise data analytics and advanced analytics. Ebiquity’s data …
  • Ana Holdings Inc:企業の戦略・SWOT・財務分析
    Ana Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Ana Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • BioMotiv LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary BioMotiv LLC (BioMotiv) is a therapeutics licensing and development service provider. The company offers therapeutics across wide disease areas including proteins, small molecules, antibodies, and nucleotides. It portfolio includes psoriasis, inflammatory bowel diseases, cancer, retinitis pi …
  • Sabah Electricity Sdn Bhd:企業の戦略的SWOT分析
    Sabah Electricity Sdn Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • IBEX Technologies Inc (IBT):企業の財務・戦略的SWOT分析
    Summary IBEX Technologies Inc (IBEX) is a manufacturer and marketer of high-purity proprietary enzymes and recombinant from flavobacterium heparinum. The company provides enzymes such as heparinase I, heparinase II, heparinase III, chondroitinase AC and chondroitinase B. Its assays allow for the stu …
  • U-Shin Ltd.:企業の戦略的SWOT分析
    U-Shin Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆